Mirna Therapeutics

Press Releases

• 01-05-12

  Mirna Therapeutics to Present at Biotech Showcase 2012
  
  Read All

• 12-23-11

  Marina Biotech and Mirna Therapeutics Announce License Agreement for the Development of microRNA-based Therapeutics
  
  Read All

• 11-15-11

  Mirna Therapeutics Presents New Data on the Development of miRNA-based Therapeutic Candidates for Hepatocellular Carcinoma
  
  Read All

• 8-23-11

  Mirna Therapeutics Announces Completion of Financing Round
  
  Read All

• 7-20-11

  Mirna Therapeutics Announces Allowance of Multiple Patents for Therapeutic Use of Tumor Suppressor miRNAs
  
  Read All

• 6-27-11

  Mirna Therapeutics to Moderate Session on Promise of miRNAs in Cancer at BIO International Convention
  
  Read All

• 6-15-11

  Mirna Therapeutics Announces Dr. Art Krieg as Scientific Advisor
  
  Read All

• 4-06-11

  Mirna Therapeutics Reports Notice of Allowance from USPTO Related to the Clinical Application of miR-34a, a Key Tumor Suppressor miRNA
  
  Read All

• 3-23-11

  Mirna Therapeutics and Collaborators Publish New Data on in vivo Delivery of microRNA Mimics
  
  Read All

• 1-18-11

  Mirna Therapeutics and Collaborators Publish New Data on miR-34 and its Role in Cancer Stem Cells
  
  Read All

• 11-16-10

  Mirna Therapeutics Presents New Data on microRNA Replacement Therapy Approach at CPRIT’s Innovations in Cancer Prevention & Research Conference
  
  Read All

• 11-02-10

  Horizon Discovery and Mirna Therapeutics to Test Activities of Tumor Suppressor MicroRNAs Using Patient-Relevant Cancer Cell Models
  
  Read All

• 10-19-10

  Mirna Therapeutics Reports Notice of Allowance from USPTO Related to the Clinical Application of an Important Cancer-Related miRNA
  
  Read All

• 10-14-10

  Mirna Therapeutics Announces Dr. David Johnson as Scientific Advisor
  
  Read All

• 06-29-10

  Mirna Therapeutics Publishes Data Demonstrating In Vivo Proof of Concept for miR-34a microRNA Replacement Therapy in Cancer
  
  Read All

• 06-21-10

  Mirna Therapeutics recommended for $10 million commercialization award from the Cancer Prevention and Research Institute of Texas
  
  Read All

• 02-03-10

  Mirna Therapeutics Announces Dr. Frank Slack as Scientific Advisor
  
  Read All

• 01-11-10

  Mirna Therapeutics Announces $5 million Award from Texas Emerging Technology Fund
  
  Read All

• 12-15-09

  Mirna Therapeutics, Inc. Appoints Three External Directors to its Board
  
  Read All

• 12-07-09

  Tiny RNA Has Big Impact On Lung Cancer Tumors
  
  Read All

• 11-12-09

  Mirna Therapeutics appoints Dr. Paul Lammers as President and CEO
  
  Read All

• 06-15-09

  Mirna Therapeutics presents data at Keystone Symposium on MicroRNA and Cancer
  
  Read All

• 02-03-09

  Mirna Therapeutics and UCSF Researchers Initiate Collaboration to Explore Therapeutic Potential of microRNAs
  
  Read All

• 01-28-09

  Mirna Therapeutics to Collaborate with M. D. Anderson on miRNA Prostate Cancer Therapeutics
  
  Read All

• 03-31-08

  Asuragen launches Mirna Therapeutics to Develop and Commercialize microRNA Oncology Therapeutics
  
  Read All

• 03-25-08

  Yale and Asuragen Scientists Show That a microRNA Can Reduce Lung Cancer Growth
  
  Read All

• 01-09-07

  Asuragen Enters Into License Agreement with Yale for Therapeutic Use of let-7 miRNA
  
  Read All